- Home
- ECBK vs SGMO Comparison
ECBK vs SGMO Comparison
Compare ECBK & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECBK
- SGMO
- Stock Information
- Founded
- ECBK 1919
- SGMO 1995
- Country
- ECBK United States
- SGMO United States
- Employees
- ECBK N/A
- SGMO N/A
- Industry
- ECBK Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECBK Finance
- SGMO Health Care
- Exchange
- ECBK Nasdaq
- SGMO Nasdaq
- Market Cap
- ECBK 151.0M
- SGMO 122.8M
- IPO Year
- ECBK N/A
- SGMO 2000
- Fundamental
- Price
- ECBK $15.83
- SGMO $0.55
- Analyst Decision
- ECBK
- SGMO Buy
- Analyst Count
- ECBK 0
- SGMO 6
- Target Price
- ECBK N/A
- SGMO $4.50
- AVG Volume (30 Days)
- ECBK 15.7K
- SGMO 5.7M
- Earning Date
- ECBK 07-24-2025
- SGMO 08-12-2025
- Dividend Yield
- ECBK N/A
- SGMO N/A
- EPS Growth
- ECBK 52.06
- SGMO N/A
- EPS
- ECBK 0.64
- SGMO N/A
- Revenue
- ECBK $27,795,000.00
- SGMO $63,756,000.00
- Revenue This Year
- ECBK N/A
- SGMO $1.29
- Revenue Next Year
- ECBK N/A
- SGMO $1.60
- P/E Ratio
- ECBK $25.16
- SGMO N/A
- Revenue Growth
- ECBK 12.29
- SGMO 239.92
- 52 Week Low
- ECBK $12.50
- SGMO $0.41
- 52 Week High
- ECBK $16.99
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ECBK 47.35
- SGMO 52.26
- Support Level
- ECBK $15.97
- SGMO $0.50
- Resistance Level
- ECBK $16.44
- SGMO $0.70
- Average True Range (ATR)
- ECBK 0.37
- SGMO 0.04
- MACD
- ECBK -0.02
- SGMO 0.01
- Stochastic Oscillator
- ECBK 5.88
- SGMO 32.61
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.